Search
News
Priorities for closing gaps in infectious-disease screening and prevention service coverage
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.
News
Viral hepatitis: testing saves lives
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
Publication
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
Publication
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Publication
ECDC/EMCDDA report: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 2
Publication
ECDC/EMCDDA report: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1
Behavioural surveillance toolkitArchived
The overall objective of this work is to support the development of a key set of indicators in order to ensure availability of comparable behavioural data and to support Member States to implement behavioural surveillance or surveys by preparing a user-friendly toolkit and framework (protocol) for the implementation of behavioural surveillance and second generation surveillance related to HIV and STI in Europe.
Data
World Hepatitis Day 2016
This infographic explains the different types of hepatitis and explains what has to be done to eliminate viral hepatits as a public health threat in Europe
Data
Table 2. Number and rate of reported hepatitis C cases per 100 000 population, EU/EEA, 2010–2014†
Number and rate of reported hepatitis C cases per 100 000 population, EU/EEA, 2010–2014†